{"id":"W3022359034","doi":"10.1002/hon.2437_133","title":"IBRUTINIB VS TEMSIROLIMUS: THREE‐YEAR FOLLOW‐UP OF PATIENTS WITH PREVIOUSLY TREATED MANTLE CELL LYMPHOMA FROM THE PHASE 3, INTERNATIONAL, RANDOMIZED, OPEN‐LABEL RAY STUDY","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Internal medicine; Mantle cell lymphoma; Temsirolimus; Refractory (planetary science); Ibrutinib; Progression-free survival; Gastroenterology; Phases of clinical research; Neutropenia; Tolerability; Toxicity; Surgery; Adverse effect; Lymphoma; Chemotherapy; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003490562,0.00108105,0.002064393,0.0004312069,0.0006183768,0.001154372,0.0008199985,0.001542526,0.002861248],"category_scores_gemma":[0.001694445,0.0006413568,0.002979864,0.0005007574,0.0005079197,0.001025773,0.0006394696,0.003063297,0.0007276498],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009222812,"about_ca_system_score_gemma":0.0008479745,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001351139,"about_ca_topic_score_gemma":0.002082534,"domain_scores_codex":[0.9990582,0.0004325096,0.00007540969,0.0001725599,0.00009626869,0.0001651628],"domain_scores_gemma":[0.9987115,0.0002167294,0.0003936524,0.0001318691,0.00008427318,0.00046201],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.946041,0.005721659,0.02599677,0.0002646687,0.002714797,0.00009938562,0.0001435316,0.0004116647,0.00226953,0.00004805612,0.0008919565,0.015397],"study_design_scores_gemma":[0.5235937,0.2527688,0.2089691,0.0001487165,0.007467262,0.0003017996,0.000172752,0.001563883,0.001444783,0.0002662836,0.003216502,0.00008646588],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942977,0.003025495,0.000172226,0.0001994698,0.00009722915,0.000491086,0.0009815241,0.0000189824,0.0007164249],"genre_scores_gemma":[0.9944227,0.0009727249,0.0002448864,0.0005596185,0.0001526995,0.0006111547,0.002269719,0.000007572079,0.0007588982],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003490562,"threshold_uncertainty_score":0.01846009,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06600161204894871,"score_gpt":0.3834560218168101,"score_spread":0.3174544097678614,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}